Superior orbital fissure syndrome in herpes zoster ophthalmicus

Kirwan, R.P.; Abdalla, M. A.; Hogan, Aisling; Tubridy, Niall; Barry, Peter; Power, William

doi:10.1007/s11845-008-0266-4

Cited by 5 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Herpes zoster is a localized disease characterised by unilateral radicular pain and a vesicular eruption caused by varicella zoster virus which is a human neurotropic DNA virus [1, 2]. Orbital involvement with HZO includes keratoconjunctivitis, anterior uveitis, acute retinal necrosis, acute phthisis bulbi, central retinal artery occlusion, optic neuritis, orbital pseudotumor, and partial or complete paralysis of ocular motility [3–6].…”

Section: Introductionmentioning

confidence: 99%

Orbital Apex Syndrome in Herpes Zoster Ophthalmicus

Arda

Mirza

Gümüş

et al. 2012

Case Reports in Ophthalmological Medicine

View full text Add to dashboard Cite

Orbital apex syndrome is a rare manifestation of Herpes Zoster Ophthalmicus. Herein we report on a case of orbital apex syndrome secondary to Herpes Zoster Ophthalmicus. A 75 year-old male complained of vision loss, conjunctival hyperemia and proptosis on the left eye, was referred to our clinic. Visual acuity was 5/10 Snellen lines and he had conjunctival hyperemia, chemosis, minimal nuclear cataract and proptosis on the left eye. A diagnosis of orbital pseudotumor was demonstrated firstly. The patient received oral and topical corticosteroids, antiinflammatory and antibiotic agents. On day 2, vesiculopustular lesions were observed, Herpes Zoster Ophthalmicus was diagnosed and corticosteroid treatment stopped, oral acyclovir treatment initiated. Two days later, total ophthalmoplegia, ptosis and significant visual loss were observed on the left. The diagnosis of orbital apex syndrome was considered and the patient commenced on an intravenous acyclovir treatment. After the improvement of acute symptoms, a tapering dose of oral cortisone treatment initiated to accelarate the recovery of ophthalmoplegia. At 5-month follow-up, ptosis and ocular motility showed improvement. VA did not significantly improve because of cataract and choroidal detachment on the left. We conclude that ophthalmoplegia secondary to Herpes Zoster Ophthalmicus responds favourably to intravenous acyclovir and steroids.

show abstract

Section: Introductionmentioning

confidence: 99%

Orbital Apex Syndrome in Herpes Zoster Ophthalmicus

Arda

Mirza

Gümüş

et al. 2012

Case Reports in Ophthalmological Medicine

View full text Add to dashboard Cite

show abstract

“…In addition, few cases of total ophthalmoplegia due to HZO have been reported, with only four cases of SOFS secondary to HZO in the current literature. [ 2 5 6 7 ] Kirwan et al . reported a case of HZO in a 71-year-old man, which subsequently developed SOFS and herpes zoster encephalitis.…”

Section: Discussionmentioning

confidence: 99%

“…reported a case of HZO in a 71-year-old man, which subsequently developed SOFS and herpes zoster encephalitis. [ 7 ]…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Herpes zoster ophthalmicus presenting as orbital abscess along with superior orbital fissure syndrome: A case report

Lavaju

Badhu

Shah

2015

Indian J Ophthalmol

View full text Add to dashboard Cite

Orbital abscess and superior orbital fissure syndrome (SOFS) are rare manifestations of herpes zoster ophthalmicus. Herein, we report a case of orbital abscess along with SOFS in a 2.5-year-old-male child secondary to herpes zoster infection. He presented with a 5-day history of proptosis and ptosis of the right eye that had been preceded by vesicular eruptions on the right forehead and scalp. Computed tomography scan of the head and orbit showed orbital abscess and right cavernous sinus thrombosis. A diagnosis of orbital abscess with SOFS secondary to herpes infection was made. The condition subsequently improved following antiviral therapy, intravenous vancomycin and amikacin, and oral corticosteroids.

show abstract

“…Èìåþòñÿ ñîîáùåíèÿ î ñèíäðîìå âåðõíåé ãëàç-íè÷íîé ùåëè ïðè ïîðàaeåíèè âèðóñîì ãåðïåñ çîñòåð: ïòîç âåðõíåãî âåêà, ïîëíàÿ îôòàëüìîïëåãèÿ, ðàñøèðåíèå çðà÷êà è îòñóòñòâèå åãî ðåàêöèè íà ñâåò, áîëè è ñíèaeåíèå ÷óâñòâèòåëüíîñòè â îáëàñòè èííåðâàöèè ïåðâîé âåòâè òðîéíè÷íîãî íåðâà (ðîãîâèöà, âåðõíåå âåêî, ïîëîâèíà ëáà). Ïðèìåíåíèå àöèêëîâèðà è ïðåäíèçîëîíà ñèñòåìíî ïîçâîëèëî âîññòàíîâèòü çðåíèå è ïîäâèaeíîñòü ãëàçíîãî ÿáëîêà, à òàêaeå -óìåíüøèòü ïòîç [6,15].…”

unclassified